CRISPRMED24 Newsletter

Important Dates

• Early bird registration open until December 1st 2023.
• Abstract submission deadline January 5th 2024.

More details here.

Meet the Keynote Speaker - Luigi Naldini

Luigi Naldini, M.D., Ph.D., is Professor of Cell and Tissue Biology and of Gene and Cell Therapy at the San Raffaele University School of Medicine and Scientific Director of the San Raffaele Telethon Institute for Gene Therapy (Milan, Italy). He received his medical degree from the University of Turin (Italy) and his PhD from the University “La Sapienza” of Rome (Italy).

For the past 25 years he has pioneered the development and application of lentiviral vectors for gene therapy, which have become one of the most widely used tools in biomedical research and, upon recently entering clinical testing, are providing a long-sought hope of cures for several currently untreatable and otherwise deadly human diseases. Throughout this time, he has continued to investigate new strategies to overcome the major hurdles to safe and effective gene transfer, bringing about innovative solutions that are not only being translated into new therapeutic strategies for genetic disease and cancer, but have also yielded novel insights into haematopoietic stem cell function, induction of immunological tolerance, and tumour angiogenesis.

Professor Naldini's work has also contributed to advancing the use of artificial nucleases for targeted genome editing in cell- and gene therapy. To date, he has published over 290 scientific papers, and his SCOPUS Author h-index is 105. He is also co-founder of three innovative biotech start-up companies: Genenta (recently listed on Nasdaq), Epsilen Bio (now acquired by Chroma Medicine) and Genespire.

View the full list of invited speakers.

Sponsors - Welcome to Broken String Biosciences

Broken String Bioscience’s technology platform, INDUCE-seq, supports the development of cell and gene therapies that are safer by design.

Few sponsorship packages are still available.

Delegates 

• CRISPRMED24 Workshops - Remember only 30 seats available per workshop.
• Oral presentations - 25 abstracts will be selected for oral presentations. Remember to submit your abstract before deadline January 5th 2024.
• All accepted abstracts will also be shared on CRISPR Medicine News, CMN.

Who will you meet at CRISPRMED24?

Any questions, please contact the CRISPRMED24 Team at: info@crisprmedicineconference.com